Table 1 Patient’s characteristics
| Â | PGx-guided group | Control group |
|---|---|---|
Gender (%) | ||
All | 113 | 130 |
Male | 62 (54.8%) | 75 (57.6%) |
Female | 51 (45.1%) | 55 (42.3%) |
Indication | ||
STEMI | 13 | 13 |
NSTEMI | 52 | 0 |
ACS | 3 | 33 |
Heart failure | 3 | 10 |
Unstable angina | 13 | 11 |
PCI | 5 | 0 |
MI | 4 | 60 |
Catheterization | 7 | 0 |
Chest pain | 3 | 0 |
Coronariography | 5 | 0 |
Coronary Artery Disease | 5 | 0 |
Aortic Stenosis | 0 | 3 |
Genotype | ||
All | 113 | 130 |
Wild-type | 47 | 60 |
Poor Metabolizer | 5 | 2 |
Intermediate Metabolizer | 20 | 30 |
Extensive metabolizer | 34 | 38 |
Ultra-metabolizer | 7 | 0 |
Age (SD) | ||
All | 74 (11.8) | 78 (10.2) |
Male | 71 (13.5) | 76 (10.1) |
Female | 76 (8.6) | 81 (9.9) |
BMI (SD) | ||
All | 27,64 (4.4) | 27,98 (4.3) |
Male | 27,19 (4.6) | 27,77 (3.8) |
Female | 28,19 (4.2) | 28,27 (4.8) |
Smoking (%) | ||
Non-Smoker | 60 (53%) | 71 (54.6%) |
Previous smoker | 45 (39.8%) | 43 (33%) |
Current smoker | 8 (7%) | 16 (12.3%) |
Alcohol consumption %* | ||
All | 21 | 30 |
Male | 16 (76.1%) | 30 (100%) |
Female | 5 (23.8%) | 0 |
Diabetes (%)** | ||
All | 45 | 55 |
Male | 24 (53.3%) | 38 (69%) |
Female | 21 (46.6%) | 17 (30.9%) |
Hypertension (%) | ||
All | 75 | 20 |
Male | 39 (52%) | 10 (50%) |
Female | 36 (48%) | 10 (50%) |